Mood or behaviour changes low incidence, with only 1.2% of total safety reports for GLP-1 agonists
2/ Types of weight-loss drugs 3/ Common weight-loss medications 4/ Benefits of weight-loss medications 5/ Who qualifies for weight-loss drugs
Patients with a history of pancreatitis, severe gastrointestinal disease, or thyroid cancer are typically not candidates
Members access detailed dosing protocols, reconstitution calculators, expert-reviewed guides, and a community of thousands who have navigated every question covered in this guide and many more that arise along the way
[DOI] [PMC free article] [PubMed] [Google Scholar] 173.Fitch A., Alexander L., Brown C.F., Bays H.E
Liraglutide (Victoza), injectable semaglutide (Ozempic), and dulaglutide (Trulicity) have demonstrated statistically significant reductions in major adverse cardiovascular events in clinical trials